You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PIK3CA-mutated

Showing 1 - 25 of 1,119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 30, 2023

Metastatic Breast Cancer Trial (Inavolisib, Phesgo, Placebo)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jun 7, 2023

Breast Cancer, PI3K, Alpelisib Trial in France (Alpelisib, Chemotherapy)

Active, not recruiting
  • Breast Cancer, PI3K, Alpelisib
  • Angers, France
  • +13 more
Mar 8, 2022

Endometroid Endometrial Cancer Trial in Baltimore (Alpelisib Pill, Fulvestrant injection)

Not yet recruiting
  • Endometroid Endometrial Cancer
  • Alpelisib Pill
  • Fulvestrant injection
  • Baltimore, Maryland
    Johns Hopkins Medicine
Dec 7, 2021

Tumor, Breast, Congenital, Familial and Genetic Disorders Trial in Netherlands (Alpelisib 150 MG Oral Tablet [Piqray],

Recruiting
  • Neoplasm, Breast
  • Congenital, Familial and Genetic Disorders
  • Almelo, Netherlands
  • +15 more
Jan 11, 2023

Brain Metastases, Leptomeningeal Metastasis Trial in United States (GDC-0084, whole brain radiation therapy radiation)

Recruiting
  • Brain Metastases
  • Leptomeningeal Metastasis
  • GDC-0084
  • whole brain radiation therapy radiation
  • Miami, Florida
  • +9 more
Jan 3, 2023

HNSCC Trial in United States (Tipifarnib, Alpelisib)

Recruiting
  • HNSCC
  • Duarte, California
  • +10 more
Jun 30, 2022

Lymphatic Malformations Trial (Alpelisib, Placebo)

Not yet recruiting
  • Lymphatic Malformations
  • (no location specified)
Jul 4, 2023

Metastatic Colorectal Cancer Trial in Worldwide (MEN1611, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Phoenix, Arizona
  • +26 more
Feb 14, 2022

Advanced Breast Cancer Trial in Worldwide (Trastuzumab, Alpelisib, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Trastuzumab
  • +5 more
  • Graz, Austria
  • +107 more
Aug 8, 2022

PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)

Completed
  • PIK3CA Mutation-Related Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 9, 2023

HER2-positive Breast Cancer Trial in Rome (PIK3CA analysis)

Active, not recruiting
  • HER2-positive Breast Cancer
  • PIK3CA analysis
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Advanced or Metastatic Breast Cancer Trial in Worldwide (MEN1611, Trastuzumab, Fulvestrant)

Active, not recruiting
  • Advanced or Metastatic Breast Cancer
  • Fort Lauderdale, Florida
  • +26 more
Feb 14, 2022

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (MEN1611, Eribulin)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • (no location specified)
Apr 12, 2023

Patterns Among PIK3CA Mutation in Advanced Breast Cancer

Completed
  • Breast Cancer
    • East Hanover, New Jersey
      Novartis
    Aug 1, 2023

    Advanced Solid Tumor, PIK3CA Mutation, PTEN Loss of Function Mutation Trial in United States (Serabelisib, Insulin Suppressing

    Recruiting
    • Advanced Solid Tumor
    • +2 more
    • Birmingham, Alabama
    • +9 more
    May 25, 2022

    Breast Cancer Stage IV Trial in Nice, Villejuif (Alpelisib, Ribociclib)

    Not yet recruiting
    • Breast Cancer Stage IV
    • Nice, France
    • +1 more
    Nov 14, 2022

    PIK3CA-Related Overgrowth Spectrum (PROS) Trial in Worldwide (alpelisib)

    Available
    • PIK3CA-Related Overgrowth Spectrum (PROS)
    • (no location specified)
    Sep 9, 2022

    Colon Cancer Trial in Worldwide (Aspirin, Placebo)

    Active, not recruiting
    • Colon Cancer
    • Brussels, Belgium
    • +51 more
    Mar 10, 2022

    HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

    Recruiting
    • HR+/HER2- Advanced Breast Cancer
    • Targeted Therapy
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Aug 1, 2023

    Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

    Not yet recruiting
    • PIK3CA-related Overgrowth Spectrum
    • +8 more
    • national registry
    • Paris, France
      Translational medicine and Targeted therapies unit, Hôpital Neck
    Sep 28, 2022

    Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

    Recruiting
    • Endometrial Cancer
    • Ovarian Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 27, 2022

    HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

    Recruiting
    • HER2-positive Metastatic Breast Cancer
    • Aurora, Colorado
    • +2 more
    Dec 29, 2022

    Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Anaheim, California
    • +47 more
    Mar 28, 2022

    Health-related Quality of Life, Symptom Severity, and Pain Among

    Recruiting
    • PIK3CA-related Overgrowth Spectrum
    • Alpelisib
    • East Hanover, New Jersey
      Novartis Investigative Site
    Jun 14, 2022